At a glance
- Originator Chiesi
- Class Analgesics; Antipyretics; Nonsteroidal anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 31 Mar 1995 Discontinued-Preclinical for Inflammation in Italy (Unknown route)